Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 7:5:177-83.

Bactericidal effects of silver plus titanium dioxide-coated endotracheal tubes on Pseudomonas aeruginosa and Staphylococcus aureus

Affiliations

Bactericidal effects of silver plus titanium dioxide-coated endotracheal tubes on Pseudomonas aeruginosa and Staphylococcus aureus

Keiko M Tarquinio et al. Int J Nanomedicine. .

Abstract

Purpose: Ventilator-associated pneumonia (VAP) is a nosocomial infection resulting in significant morbidity and mortality. Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aureus (S. aureus) are pathogens associated with VAP. Silver (Ag) coating of endotracheal tubes (ETTs) reduces bacterial colonization, however titanium dioxide (TiO(2)) coating has not been studied.

Methods: Five types of ETT coatings were applied over silica layer: Ag, solgel TiO(2), solgel TiO(2) with Ag, Degussa P25 TiO(2) (Degussa TiO(2)), and Degussa TiO(2) with Ag. After ETTs were incubated with P. aeruginosa or S. aureus; colonization was determined quantitatively.

Results: Pseudomonas aeruginosa and S. aureus grew for 5 days on standard ETTs. Compared to standard ETTs, P. aeruginosa growth was significantly inhibited by solgel TiO(2) with Ag at 24 hours, and by Degussa TiO(2) with Ag at 24 and 48 hours after inoculation. No significant difference in S. aureus growth was observed between the control and any of the five coatings for 5 days.

Conclusion: In vitro, solgel TiO(2) with Ag and Degussa TiO(2) with Ag both attenuated P. aeruginosa growth, but demonstrated no effect on S. aureus colonization. Further studies using alternative coating and incorporating UV light exposure are needed to identify their potential utility in reducing VAP.

Keywords: Degussa titanium dioxide; quantitative culture; solgel titanium dioxide; ventilator-associated pneumonia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Standard endotracheal tubes were coated with a passivating layer of colloidal silica and served as controls. Five types of coatings were applied over a silica layer; 1. solgel titanium dioxide without silver, 2. solgel titanium dioxide with silver, 3. Degussa titanium dioxide without silver, 4. Degussa titanium dioxide with silver and 5. silver only (not shown).
Figure 2
Figure 2
Characterization of P. aeruginosa growth on polyvinyl chloride endotracheal tubes over a 144-hour period. Comparison of standard and silver only coated endotracheal tubes. There was less P. aeruginosa growth on silver-coated endotracheal tubes at 24 hours (P < 0.01), but more growth at 120 hours (P = 0.04) and 144 hours (P = 0.06) compared to standard endotracheal tubes. Notes: Mean ± standard error of mean, *P < 0.05 compared to standard endotracheal tube. N = 4. Abbreviation: CFU, colony-forming units.
Figure 3
Figure 3
Characterization of P. aeruginosa growth on polyvinyl chloride endotracheal tubes coated with titanium dioxide over 144 hour period. Comparison of standard, solgel titanium dioxide and Degussa titanium dioxide endotracheal tubes. P. aeruginosa growth was not statistically significant at all time points. Notes: Mean ± standard error of mean, N = 4. Abbreviation: CFU, colony-forming units.
Figure 4
Figure 4
Characterization of P. aeruginosa growth on polyvinyl chloride endotracheal tubes coated with titanium dioxide with silver over a 144-hour period. Comparison of standard, solgel titanium dioxide with silver, and Degussa titanium dioxide with silver endotracheal tubes. P. aeruginosa growth was inhibited significantly by solgel titanium dioxide with silver at 24 hours and by Degussa titanium dioxide with silver at 24 and 48 hours, respectively. Notes: Mean ± standard error of mean; *P < 0.05 compared to standard endotracheal tube, # P < 0.05 compared to standard endotracheal tube. N = 4. Abbreviation: CFU, colony-forming units.
Figure 5
Figure 5
Characterization of S. aureus growth on polyvinyl chloride endotracheal tubes coated with silver only over a 144-hour period. Comparison of standard and silver only coated endotracheal tubes. There was no difference in S. aureus growth between standard and silver coated endotracheal tubes at any time point over 144 hours compared with standard endotracheal tubes. Note: N = 4. Abbreviation: CFU, colony-forming units.
Figure 6
Figure 6
Characterization of S. aureus growth on polyvinyl chloride endotracheal tubes coated with titanium dioxide only over a 144-hour period. Comparison of standard, solgel titanium dioxide and Degussa titanium dioxide endotracheal tubes. There was no difference in S. aureus growth in the titanium dioxide-coated groups compared to standard endotracheal tubes at any time point. Note: N = 4. Abbreviation: CFU, colony-forming units.
Figure 7
Figure 7
Characterization of S. aureus growth on polyvinyl chloride endotracheal tubes coated with titanium dioxide with silver over a 144-hour period. Comparison of standard, solgel titanium dioxide with silver and Degussa titanium dioxide with silver endotracheal tubes. There was no difference in S. aureus growth in the titanium dioxide with silver-coated groups compared to standard endotracheal tubes except at 144 hours with solgel titanium dioxide with silver endotracheal tubes. Note: N = 4. Abbreviation: CFU, colony-forming units.

Similar articles

Cited by

References

    1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903. - PubMed
    1. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics. 2002;109:758–764. - PubMed
    1. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312–1317. - PubMed
    1. Cook D, Reeve B, Guyatt G, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275:308–314. - PubMed
    1. Crnich C, Safdar N, Maki D. The role of the intensive care unit environment in the pathogenesis and prevention of ventilator-associated pneumonia. Respir Care. 2005;50:813–836. discussion, 836–818. - PubMed

MeSH terms

LinkOut - more resources